Schultz to head CDRH for rest of 2004?
This article was originally published in The Gray Sheet
Executive Summary
Device center medical deputy post unlikely to be filled until CDRH obtains a permanent director, according to FDA staff. The agency had previously suggested that a medical deputy appointment was imminent, and that more than 20 candidates were under review (1"The Gray Sheet" April 19, 2004, p. 3). With the April 30 departure of former CDRH director David Feigal, however, staffers say Dan Schultz could remain acting director through the November elections...
You may also be interested in...
CDRH Leadership Changes May Be Imminent; NCI’s Ellen Feigal To Leave Institute
FDA is vetting a list of more than 20 candidates for a CDRH clinical deputy spot - a position that may grow in stature with the potential departure of Director David Feigal
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.